Biox-Vision
Latest round
- Series A
Last raised
- Jul 2017
Total raised
- Undisclosed
Investors
- 2
About Biox-Vision
Founded in 2013 and based in Hefei, China, Biox-Vision operates as a biotechnology company that focuses on antigen and antibody R&D and application services. It was recognized as the National High-tech Enterprise. The company has 4 branch offices. It acquired the Medical Device Business License in 2019. Biox-Vision's main business is antigen and antibody research and development and application services. Its main products are tumor antibody drugs, including monoclonal antibody PD1 monoclonal antibody, anti-PD1-anti-CD40 antibody, etc. The PD1 antibody-directed targeted therapy developed by it can alleviate the pain caused by radiotherapy and chemotherapy to cancer patients. The company also provides rapid test kits, folate receptor test kits and other test kits. The company generates revenue by providing antibody R&D and application services.
Who invested in Biox-Vision
2 investors across 2 rounds
See all investors in Biox-Vision
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biox-Vision
Who invested in Biox-Vision?
Biox-Vision has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biox-Vision raised?
Biox-Vision has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Biox-Vision last raise money?
Biox-Vision's most recent round on record is a Series A, in Jul 2017.
What does Biox-Vision do?
Founded in 2013 and based in Hefei, China, Biox-Vision operates as a biotechnology company that focuses on antigen and antibody R&D and application services.
Where is Biox-Vision headquartered?
Biox-Vision is headquartered in Hefei, China.
Which VCs invest in companies like Biox-Vision?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Biox-Vision's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Biox-Vision? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.